A partially randomised trial of pretomanid, moxifloxacin and pyrazinamide for pulmonary TB
一项关于普瑞托马尼、莫西沙星和吡嗪酰胺治疗肺结核的部分随机试验
期刊:International Journal of Tuberculosis and Lung Disease
影响因子:3.1
doi:10.5588/ijtld.20.0513
Tweed, C D; Wills, G H; Crook, A M; Amukoye, E; Balanag, V; Ban, A Y L; Bateson, A L C; Betteridge, M C; Brumskine, W; Caoili, J; Chaisson, R E; Cevik, M; Conradie, F; Dawson, R; Del Parigi, A; Diacon, A; Everitt, D E; Fabiane, S M; Hunt, R; Ismail, A I; Lalloo, U; Lombard, L; Louw, C; Malahleha, M; McHugh, T D; Mendel, C M; Mhimbira, F; Moodliar, R N; Nduba, V; Nunn, A J; Sabi, I; Sebe, M A; Selepe, R A P; Staples, S; Swindells, S; van Niekerk, C H; Variava, E; Spigelman, M; Gillespie, S H